Biologicals for Cancer Treatment: Monoclonal Antibodies

Publisher Website
Google Scholar
Abstract
The use of monoclonal antibodies against human tumor cells is a theoretically highly attractive approach to cancer therapy. And technologically, the capability seems to be available. Problems such as defining the optimum antigens—and their antibodies—are currently being investigated intensively. Progress in this research and its clinical significance are reviewed.